Gaush Meditech Ltd
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalm… Read more
Gaush Meditech Ltd - Asset Resilience Ratio
Gaush Meditech Ltd (F7Y) has an Asset Resilience Ratio of 2.41% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Gaush Meditech Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Gaush Meditech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €61.97 Million | 2.41% |
| Total Liquid Assets | €61.97 Million | 2.41% |
Asset Resilience Insights
- Limited Liquidity: Gaush Meditech Ltd maintains only 2.41% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Gaush Meditech Ltd Industry Peers by Asset Resilience Ratio
Compare Gaush Meditech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Gaush Meditech Ltd (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Gaush Meditech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.81% | €97.68 Million | €2.57 Billion | -3.73pp |
| 2023-12-31 | 7.54% | €214.34 Million | €2.84 Billion | +4.13pp |
| 2022-12-31 | 3.41% | €92.64 Million | €2.72 Billion | -- |